Liao, Wenting <br/><br/>
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.  [electronic resource] 

 -  Cancer cell  04 2019 
 - 559-572.e7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2019.02.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenomatous Polyposis Coli Protein--genetics<br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Cell Line, Tumor<br/>Cell Movement<br/>Chemokines, CXC--metabolism<br/>Colorectal Neoplasms--drug therapy<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Interferon Regulatory Factor-2--genetics<br/>Male<br/>Mice, Inbred C57BL<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Mice, Transgenic<br/>Middle Aged<br/>Myeloid-Derived Suppressor Cells--drug effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Receptors, Interleukin-8B--metabolism<br/>Signal Transduction<br/>Tumor Escape<br/>Tumor Microenvironment<br/>Tumor Suppressor Protein p53--genetics<br/>Young Adult